Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02267044 · ClinicalTrials.gov registry record · NA
Effective Pain Management of Interscalene Blocks During Shoulder Surgery
A NA study of Primary Osteoarthritis, Unspecified Shoulder, sponsored by TriHealth.
- Completed
- Registry status
- NA
- Development phase
- 76
- Enrollment target
- 1
- Study location
NCT02267044 is a NA study of Primary Osteoarthritis, Unspecified Shoulder that has completed, run by TriHealth. The registered enrollment target is 76 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02267044, a NA study of Primary Osteoarthritis, Unspecified Shoulder, has completed, sponsored by TriHealth.
- COMPLETED
- Registry status
- NA
- Development phase
- 76 participants
- Enrollment target
- 1
- Study location
Study Summary
Shoulder replacement surgery is recognized as having the potential to cause a considerable amount of postoperative pain. Adequate management of pain after surgery is necessary not only to improve the patient's wellbeing but also to facilitate recovery. Several regional anesthesia techniques are available to combat postoperative pain in the shoulder replacement surgery patient, however, which method provides superior pain relief remains unknown. The purpose of this study is to examine the effectiveness of a continuous interscalene block versus a single shot interscalene block for postoperative pain relief in the shoulder replacement patient. Patients undergoing shoulder replacement surgery will experience more effective pain relief with a continuous interscalene block versus and single shot interscalene block.
Conditions Studied
Interventions
- DRUG Ropivacaine
Study Locations (1)
Ohio
- Good Samaritan Hospital - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2014-08 |
| Est. Completion | 2017-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02267044
The ClinicalTrials.gov registry entry for NCT02267044 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 76 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is TriHealth, which has 81 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Primary Osteoarthritis, Unspecified Shoulder appearing as the primary indexed condition, and to 1 intervention - of which Ropivacaine is the first listed.
NCT02267044 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT02267044 about?
NCT02267044 is a clinical study titled "Effective Pain Management of Interscalene Blocks During Shoulder Surgery". Shoulder replacement surgery is recognized as having the potential to cause a considerable amount of postoperative pain. Adequate management of pain after surgery is necessary not only to improve the patient's wellbeing but also to facilitate recovery. Several regional anesthesia techniques are avai...
What is the current status of trial NCT02267044?
This trial is currently completed. It is a NA study. The enrollment target is 76 participants. The study started on 2014-08. Estimated completion is 2017-04.
What conditions does trial NCT02267044 study?
This clinical trial studies the following conditions: Primary Osteoarthritis, Unspecified Shoulder.
What interventions are being tested in trial NCT02267044?
The interventions under investigation include: Ropivacaine (DRUG).
Who is sponsoring clinical trial NCT02267044?
This trial is sponsored by TriHealth, which has 81 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02267044 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.